These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23172306)

  • 1. Insights into the activity, differential expression, mutual regulation, and functions of matrix metalloproteinases and a disintegrin and metalloproteinases in hypertension and cardiac disease.
    Berry E; Bosonea AM; Wang X; Fernandez-Patron C
    J Vasc Res; 2013; 50(1):52-68. PubMed ID: 23172306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MMP-2 mediates angiotensin II-induced hypertension under the transcriptional control of MMP-7 and TACE.
    Odenbach J; Wang X; Cooper S; Chow FL; Oka T; Lopaschuk G; Kassiri Z; Fernandez-Patron C
    Hypertension; 2011 Jan; 57(1):123-30. PubMed ID: 21079048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase-7 and ADAM-12 (a disintegrin and metalloproteinase-12) define a signaling axis in agonist-induced hypertension and cardiac hypertrophy.
    Wang X; Chow FL; Oka T; Hao L; Lopez-Campistrous A; Kelly S; Cooper S; Odenbach J; Finegan BA; Schulz R; Kassiri Z; Lopaschuk GD; Fernandez-Patron C
    Circulation; 2009 May; 119(18):2480-9. PubMed ID: 19398663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental and clinical findings regarding matrix metalloproteinases in cardiovascular diseases.
    Ceron CS; Luizon MR
    J Vasc Res; 2013; 50(5):442-3. PubMed ID: 24080611
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor necrosis factor-alpha-converting enzyme is a key regulator of agonist-induced cardiac hypertrophy and fibrosis.
    Wang X; Oka T; Chow FL; Cooper SB; Odenbach J; Lopaschuk GD; Kassiri Z; Fernandez-Patron C
    Hypertension; 2009 Sep; 54(3):575-82. PubMed ID: 19581512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases (MMPs) in health and disease: an overview.
    Malemud CJ
    Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expressions of matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs and their endogenous inhibitors among histologic subtypes of lung cancers.
    Hida Y; Hamada J
    Anticancer Agents Med Chem; 2012 Sep; 12(7):744-52. PubMed ID: 22292754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of culture conditions and exposure to catabolic stimulators (IL-1 and retinoic acid) on the expression of matrix metalloproteinases (MMPs) and disintegrin metalloproteinases (ADAMs) by articular cartilage chondrocytes.
    Flannery CR; Little CB; Caterson B; Hughes CE
    Matrix Biol; 1999 Jun; 18(3):225-37. PubMed ID: 10429942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteinases and plaque rupture: unblocking the road to translation.
    Newby AC
    Curr Opin Lipidol; 2014 Oct; 25(5):358-66. PubMed ID: 25089553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix Metalloproteinases: How Much Can They Do?
    Ågren MS; Auf dem Keller U
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease.
    Zhong S; Khalil RA
    Biochem Pharmacol; 2019 Jun; 164():188-204. PubMed ID: 30905657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of disintegrin metalloproteinases and their inhibitor in human dilated cardiomyopathy.
    Fedak PW; Moravec CS; McCarthy PM; Altamentova SM; Wong AP; Skrtic M; Verma S; Weisel RD; Li RK
    Circulation; 2006 Jan; 113(2):238-45. PubMed ID: 16401770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of metalloproteinase expression in colorectal cancer - relation of molecular findings to basic morphology.
    Kajiwara Y; Ueno H; Hashiguchi Y; Shinto E; Shimazaki H; Mochizuki H; Hase K
    Anticancer Res; 2011 May; 31(5):1567-75. PubMed ID: 21617211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of ADAM (a disintegrin and metalloproteinase) genes between human first trimester villous and extravillous trophoblast cells.
    Takahashi H; Yuge K; Matsubara S; Ohkuchi A; Kuwata T; Usui R; Suzuki M; Takizawa T
    J Nippon Med Sch; 2014; 81(3):122-9. PubMed ID: 24998958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive gene expression profiling and functional analysis of matrix metalloproteinases and TIMPs, and identification of ADAM-10 gene expression, in a corneal model of epithelial resurfacing.
    Gordon GM; Austin JS; Sklar AL; Feuer WJ; LaGier AJ; Fini ME
    J Cell Physiol; 2011 Jun; 226(6):1461-70. PubMed ID: 20625997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of MMPs and ADAM/ADAMTS.
    Malemud CJ
    Biochem Pharmacol; 2019 Jul; 165():33-40. PubMed ID: 30826330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential hypertensive protease expression in the thoracic versus abdominal aorta.
    Ruddy JM; Akerman AW; Kimbrough D; Nadeau EK; Stroud RE; Mukherjee R; Ikonomidis JS; Jones JA
    J Vasc Surg; 2017 Nov; 66(5):1543-1552. PubMed ID: 28034583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability in melanoma metalloproteinase expression profiling.
    Giricz O; Lauer JL; Fields GB
    J Biomol Tech; 2010 Dec; 21(4):194-204. PubMed ID: 21119930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolytic Activity Matrix Analysis (PrAMA) for simultaneous determination of multiple protease activities.
    Miller MA; Barkal L; Jeng K; Herrlich A; Moss M; Griffith LG; Lauffenburger DA
    Integr Biol (Camb); 2011 Apr; 3(4):422-38. PubMed ID: 21180771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dual inhibitor of matrix metalloproteinases and a disintegrin and metalloproteinases, [¹⁸F]FB-ML5, as a molecular probe for non-invasive MMP/ADAM-targeted imaging.
    Matusiak N; Castelli R; Tuin AW; Overkleeft HS; Wisastra R; Dekker FJ; Prély LM; Bischoff R; van Waarde A; Dierckx RA; Elsinga PH
    Bioorg Med Chem; 2015 Jan; 23(1):192-202. PubMed ID: 25438884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.